Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer.
about
Serum AMH level as a marker of acute and long-term effects of chemotherapy on the ovarian follicular content: a systematic reviewSelf-collected dried blood spots as a tool for measuring ovarian reserve in young female cancer survivorsPreserving fertility in patients undergoing treatment for breast cancer: current perspectives.A highly-sensitive anti-Müllerian hormone assay improves analysis of ovarian function following chemotherapy for early breast cancer.The physiology and clinical utility of anti-Mullerian hormone in women.Prechemotherapy antimullerian hormone, age, and body size predict timing of return of ovarian function in young breast cancer patientsSexual dysfunction and infertility as late effects of cancer treatment.Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103.Ovarian Function, Not Age, Predicts the Benefit from Ovarian Suppression or Ablation for Premenopausal Women with Breast Cancer.SLCO1B1*5 polymorphism (rs4149056) is associated with chemotherapy-induced amenorrhea in premenopausal women with breast cancer: a prospective cohort study.Predicting Ovarian Activity in Women Affected by Early Breast Cancer: A Meta-Analysis-Based NomogramChemotherapy: Impact on Anti-Müllerian Hormone Levels in Breast Carcinoma.Anti Mullerian Hormone: Ovarian response indicator in young patients receiving Long GnRH Agonist Protocol for Ovarian Stimulation.Preservation of Fertility or Ovarian Function in Patients with Breast Cancer or Gynecologic and Internal Malignancies.Risk of chemotherapy-induced amenorrhea in patients with breast cancer: a systematic review and meta-analysis.Reduced ovarian reserve in young early breast cancer patients: preliminary data from a prospective cohort trial.Genetic variants of age at menopause are not related to timing of ovarian failure in breast cancer survivors.The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer.Ovarian function after chemotherapy in young breast cancer survivors.Age-specific serum anti-Müllerian hormone concentration in Japanese women and its usefulness as a predictor of the ovarian response.Assessment of ovarian function after chemotherapy in women with early and locally advanced breast cancer from Serbia.
P2860
Q28384104-8794346B-E605-433C-8ACA-6B714916B377Q28396648-A75CCFAE-B685-4912-BA3D-387C6FBF2368Q33939688-E64B2FCE-725E-4AC5-95F9-E21DBCB37935Q34199333-B70562DA-CD66-4E68-820A-B6361DEEE960Q34398233-244C586B-8DF4-4B6E-B7FF-F3F298496FA0Q34550633-B7479E0C-C759-462F-B8C0-CC2C42EFBB2EQ34604454-DA652287-9EEB-491F-A4F8-C3B0591FC374Q35100279-1103C9FE-4557-45AD-BDB0-3DB7227E7C4EQ35920776-FA35A1FD-6CA7-441E-80F5-B34E15A02EDAQ36032817-AB5CA190-A82C-42F7-BB0E-BEEE97961C38Q36116355-23E5427C-9C75-4A00-9E07-08013B79CEE7Q36708416-3C8FC8BC-97C8-4D9E-8143-E9B134D6CEF7Q37244112-6FFDC01C-1442-4D6B-9F8F-FB129DC20045Q38606467-30DF5984-5C08-4B62-BBE3-4B11408BEDC3Q38814894-3E3BB64D-1930-4DEA-BB35-47F136E2BA3EQ41594757-C0CB90A9-0111-4490-B883-00966E0E58EBQ46104269-54A7D977-A15B-4543-8FF6-F28CBA1DB75CQ47097531-118CDD42-50CC-4E51-8FFE-620CD9A358F1Q47124589-25318BD1-A3F9-4A4F-B4AE-C497C474A134Q47135963-54CC5F5D-C972-4B62-B651-FC66C3316D56Q48365999-2CBDF58A-745D-4FB6-9F7B-1844F855744A
P2860
Pretreatment anti-Müllerian hormone predicts for loss of ovarian function after chemotherapy for early breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pretreatment anti-Müllerian ho ...... erapy for early breast cancer.
@en
Pretreatment anti-Müllerian ho ...... erapy for early breast cancer.
@nl
type
label
Pretreatment anti-Müllerian ho ...... erapy for early breast cancer.
@en
Pretreatment anti-Müllerian ho ...... erapy for early breast cancer.
@nl
prefLabel
Pretreatment anti-Müllerian ho ...... erapy for early breast cancer.
@en
Pretreatment anti-Müllerian ho ...... erapy for early breast cancer.
@nl
P2860
P1476
Pretreatment anti-Müllerian ho ...... erapy for early breast cancer.
@en
P2093
David A Cameron
Richard A Anderson
P2860
P304
P356
10.1016/J.EJCA.2013.07.014
P577
2013-08-19T00:00:00Z